Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)
The purpose of this study is to determine if a single dose of pegfilgrastim is able to reduce the time of severe neutropenia in patients receiving induction and consolidation myelosuppressive chemotherapy for de novo acute myeloid leukemia similar to filgrastim.
Myeloid Leukemia
DRUG: filgrastim|DRUG: pegfilgrastim
Time to recover from severe neutropenia (ANC less that 0.5 X 10^9/L in chemotherapy Induction 1., Induction cycle 1
Duration of severe neutropenia during induction chemotherapy, Induction cycle 1
The purpose of this study is to determine if a single dose of pegfilgrastim is able to reduce the time of severe neutropenia in patients receiving induction and consolidation myelosuppressive chemotherapy for de novo acute myeloid leukemia similar to filgrastim.